Want to join the conversation?
$VAR finished the year with $845MM in cash and cash equivalents and $496MM of debt. Cash flow from operations was $153MM for 4Q15 and $470MM for the fiscal year. During the quarter, $VAR spent $128MM to repurchase about 1.5MM shares of common stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.